search
Back to results

The Impact of Serelys PMS on Symptoms of PMS

Primary Purpose

Premenstrual Syndrome

Status
Completed
Phase
Phase 3
Locations
Denmark
Study Type
Interventional
Intervention
Placebo
Serelys PMS
Sponsored by
Jens Rikardt Andersen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Premenstrual Syndrome

Eligibility Criteria

21 Years - 50 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • At least five inconveniences in the premenstrual period and which disappear quickly with the end of menstruation : Irritability, Tension, Fatigue, Dysphoria (sadness), Reduced motor coordination, Difficulty concentrating, Changes in libido, Changes in appetite.
  • these inconveniences disappear quickly with the end of menstruation
  • At least one of these criteria must be present in the premenstrual and menstrual period:

    1. Deterioration in relations with the family, at home, in school or at work
    2. Having thought to take painkillers for at least one menstrual cycle.
  • Have symptoms of dysphoria / premenstrual sadness at least during the previous 6 cycles.

Exclusion Criteria:

  • Known allergy to any component of the product and known renal and hepatic impairment.
  • Existence of major evolving pathologies
  • Convulsions. Existence of psychiatric disorders, cravings
  • Suicidal thoughts
  • Taking medications that may interfere with PMS symptoms like eg estrogens.
  • Participation in another clinical study at the same time.
  • Pregnancy and / or lactation;
  • Difficulties to collaborate and difficulties to understand and complete the questionnaires.

Sites / Locations

  • Department of Nutrition, Exercise and Sports, University of Copenhagen

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Serelys PMS

Arm Description

2 capsules daily for 2 months containing inactive substances

2 capsules daily for 2 months containing pollen extract

Outcomes

Primary Outcome Measures

PMS symptoms evaluation - Premenstrual Tension
Premenstrual Tension Scale (PMTS) - Self-rating scale
PMS symptoms evaluation - Premenstrual Tension 2
Premenstrual Tension Scale (PMTS) - Observe Rating Scale
PMS symptoms evaluation - premenstrual discomfort
Evaluation of premenstrual discomfort by Visual Analog Scales (VAS)

Secondary Outcome Measures

Side effect registration
Tolerance will be assessed through a scoring system
Satisfaction scored by the patients
Satisfaction and well-being will be assessed through a scoring system

Full Information

First Posted
September 7, 2017
Last Updated
October 12, 2018
Sponsor
Jens Rikardt Andersen
Collaborators
Serelys Pharma
search

1. Study Identification

Unique Protocol Identification Number
NCT03298607
Brief Title
The Impact of Serelys PMS on Symptoms of PMS
Official Title
The Impact of Sérélys PMS, a Herbal Remedy Based on Pollen Extraction and Saffron, on Symptoms of PMS: A Randomized, Double-blinded, Placebo Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
October 30, 2017 (Actual)
Primary Completion Date
June 1, 2018 (Actual)
Study Completion Date
June 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jens Rikardt Andersen
Collaborators
Serelys Pharma

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of the present study is to better define and evaluate Serelys PMS in terms of the impact on the different premenstrual syndrome (PMS) symptoms , tolerance, satisfaction and overall quality of life of women with known discomforts during the premenstrual period. The data from this study will be compared to data when the two different ingredients are given as monotherapy.
Detailed Description
More than every other women aged 15 to 50 years of age have premenstrual symptoms such as irritability, mood swings, fatigue, headaches, sleep disturbances, breast and abdominal pain, bloating, water retention and weight gain. Some signs continue during menstruation. These psychological and physical manifestations can make women vulnerable and have a negative impact on their professional, social and sexual life. Randomized, double-blind, placebo-controlled clinical studies demonstrated the beneficial effects of pollen extract in premenstrual discomfort. The premenstrual period is probably caused by a change in the normal amount of sex hormones which can induce disorders in the central neuroendocrine system and estrogens are reported to reduce PMS symptoms to some extend. Moreover, it is well established that serotonin may play a role in PMS, as some inhibitors of serotonin re-uptake (SSRI) have an impact on premenstrual disorders. However, side effects may occur even when using estrogens as well as SSRI. Recently the pollen extract formulation has been improved by adding a natural extract of saffron. This latter component is known for its beneficial action on maintaining comfort during the menstrual cycle of the woman and it especially supports mood changes, one of the mayor PMS symptoms. The effect of Safran was studied more specifically in a randomized controlled double-blind, placebo-controlled clinical trial in women with premenstrual discomfort. This study showed a progressive and significant improvement after the use of saffron. In an other study saffron was documented to improve mood in patients with milder depression. In summary, the components of saffron helps to improve the well-being of women during the premenstrual and menstrual period and have a well documented impact on mood. The pollen based extracts have well documented impact on most of PMS symptoms but possibly lesser on mood changes, which is also one of the mayor symptoms of PMS. The mechanisms by which saffron and pollen based extraction works is expected to be different and an additive impact is expected. The investigation is initiated by the researchers who feel that in PMS an alternatives to SSRI and estrogen treatment is needed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premenstrual Syndrome

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
2 months treatment with (Food Supplement - Serelys PMS)
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Placebo controlled
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
2 capsules daily for 2 months containing inactive substances
Arm Title
Serelys PMS
Arm Type
Active Comparator
Arm Description
2 capsules daily for 2 months containing pollen extract
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
2 months treatment
Intervention Type
Dietary Supplement
Intervention Name(s)
Serelys PMS
Intervention Description
2 months treatment
Primary Outcome Measure Information:
Title
PMS symptoms evaluation - Premenstrual Tension
Description
Premenstrual Tension Scale (PMTS) - Self-rating scale
Time Frame
2 months
Title
PMS symptoms evaluation - Premenstrual Tension 2
Description
Premenstrual Tension Scale (PMTS) - Observe Rating Scale
Time Frame
2 months
Title
PMS symptoms evaluation - premenstrual discomfort
Description
Evaluation of premenstrual discomfort by Visual Analog Scales (VAS)
Time Frame
2 months
Secondary Outcome Measure Information:
Title
Side effect registration
Description
Tolerance will be assessed through a scoring system
Time Frame
2 months
Title
Satisfaction scored by the patients
Description
Satisfaction and well-being will be assessed through a scoring system
Time Frame
2 months

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: At least five inconveniences in the premenstrual period and which disappear quickly with the end of menstruation : Irritability, Tension, Fatigue, Dysphoria (sadness), Reduced motor coordination, Difficulty concentrating, Changes in libido, Changes in appetite. these inconveniences disappear quickly with the end of menstruation At least one of these criteria must be present in the premenstrual and menstrual period: Deterioration in relations with the family, at home, in school or at work Having thought to take painkillers for at least one menstrual cycle. Have symptoms of dysphoria / premenstrual sadness at least during the previous 6 cycles. Exclusion Criteria: Known allergy to any component of the product and known renal and hepatic impairment. Existence of major evolving pathologies Convulsions. Existence of psychiatric disorders, cravings Suicidal thoughts Taking medications that may interfere with PMS symptoms like eg estrogens. Participation in another clinical study at the same time. Pregnancy and / or lactation; Difficulties to collaborate and difficulties to understand and complete the questionnaires.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kaj Winther Hansen, MD
Organizational Affiliation
UCopenhagen, Department of Nutrition, Exercise and Sport
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Nutrition, Exercise and Sports, University of Copenhagen
City
Copenhagen
ZIP/Postal Code
1958FC
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Impact of Serelys PMS on Symptoms of PMS

We'll reach out to this number within 24 hrs